AGIO Competitors & Alternatives
Compare Agios Pharm with similar stocks in the same industry
Biotechnology
AGIO
Main Stock$35.74
Tradestie Score
54
Market Cap
$2.33B
Revenue Growth
1.4%
Analyst Upside
+14.0%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$17.63
|
$2.22B | - | 59 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$55.67
|
$2.21B | - | 64 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$25.11
|
$2.18B | - | 67 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$15.43
|
$2.08B | - | 61 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.51
|
$2.02B | 50.4 | 53 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$15.32
|
$2.01B | - | 56 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$36.41
|
$1.97B | - | 63 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$10.36
|
$1.92B | - | 62 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$91.93
|
$1.92B | - | 52 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$75.67
|
$1.90B | 418.1 | 66 | Compare |
More AGIO Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry